Gabapentin Dosing Guidelines

Introduction to Gabapentin Dosing

The American Academy of Neurology recommends starting gabapentin at 300 mg three times daily (900 mg/day total) and titrating upward by 300 mg/day every 1-7 days as tolerated, with most patients achieving adequate pain relief at 1800 mg/day 1

The National Kidney Foundation suggests that gabapentin is eliminated entirely unchanged by the kidneys, making dose adjustment mandatory in renal impairment to prevent toxicity, with a recommended maximum dose reduction of at least 50% from standard dosing for moderate impairment 1
For patients with moderate renal impairment (CrCl 30-59 mL/min), the maximum dose should be reduced to 1400 mg/day divided into two daily doses, representing at least a 50% reduction from standard dosing, according to the National Institute of Diabetes and Digestive and Kidney Diseases 2

The American College of Clinical Pharmacology recommends that for severe renal impairment (CrCl 15-29 mL/min), the maximum dose should be 700 mg/day as a single daily dose, and for end-stage renal disease (CrCl <15 mL/min), the maximum dose should be 300 mg/day as a single daily dose 2

The American Geriatrics Society advises against relying on serum creatinine alone to estimate renal function, particularly in elderly patients with reduced muscle mass, and recommends using the Cockcroft-Gault equation to calculate CrCl before initiating therapy, as a "normal" creatinine of 1.0 mg/dL in an 80-year-old patient weighing 60 kg corresponds to a CrCl of approximately 40 mL/min, requiring dose reduction 2

The National Institute of Neurological Disorders and Stroke suggests that common manifestations of gabapentin toxicity in renal impairment include altered mental status, confusion with hallucinations, myoclonus, tremulousness, dizziness, somnolence, and in severe cases, coma, and recommends temporarily discontinuing gabapentin in patients with baseline CrCl <60 mL/min until renal function stabilizes if acute kidney injury develops during treatment 3

The American Academy of Pain Medicine recommends increasing gabapentin by 300 mg/day every 1-7 days for normal renal function, and by 100-300 mg every 3-7 days for any degree of renal impairment, with an adequate trial requiring 3-8 weeks for titration plus 2 weeks at the maximum tolerated dose before concluding treatment failure 1